ARCHIVES

Sponsors Withdraw Indications for Iressa, Celebrex

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984

New Model Provides Better Estimate of Breast Cancer Risk in Black Women.

November 30, 2007

In Brief: John Young to Leave NCI for ELM; Yates Looking for Chief Of Outpatient Services At RPI

March 18, 1988

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014